Cochrane Abstracts
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Perphenazine Versus Low‐potency First‐generation Antipsychotic Drugs for Schizophrenia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433341/all/Perphenazine_versus_low‐potency_first‐generation_antipsychotic_drugs_for_schizophrenia.
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/all/Perphenazine_versus_low‐potency_first‐generation_antipsychotic_drugs_for_schizophrenia. Accessed November 21, 2024.
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/all/Perphenazine_versus_low‐potency_first‐generation_antipsychotic_drugs_for_schizophrenia
Perphenazine Versus Low‐potency First‐generation Antipsychotic Drugs for Schizophrenia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/all/Perphenazine_versus_low‐potency_first‐generation_antipsychotic_drugs_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
ID - 433341
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/all/Perphenazine_versus_low‐potency_first‐generation_antipsychotic_drugs_for_schizophrenia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
